F
Fluor Corporation
FLR · Industrials
Q4 FY2025
Earning ended Dec 31, 2025Report generated Mar 10, 2026
A Genuine Turnaround Already Priced Ahead of Its Own Evidence
The market has started repricing Fluor for its reimbursable contract transformation and AI infrastructure exposure — but the stock now reflects the thesis before the execution track record does, and the Santos arbitration reveals that legacy fixed-price tail risk hasn't fully cleared the system yet.
Flowly Score
Apr 16 Close
-42%$47.88
Fair Value
$28.00
30
Weakat $47.88
Business Strength4/10
The reimbursable contract pivot and AI/semiconductor tailwinds are real, but the moat is a license to compete rather than a license to profit — scale gets you in the room, and then price decides who wins. Two expensive strategic miscalculations in a decade (fixed-price blowup, NuScale) signal that the risk management culture has been rewired at the rhetoric level faster than at the execution level.
Financial Resilience3/10
A Piotroski of 2 is not a blip — it signals widespread financial deterioration across profitability, leverage, and efficiency signals simultaneously, and the Santos arbitration payment only explains the cash drawdown, not the chronic pattern of negative free cash flow across three of the last five years. Net cash remains positive, which prevents this from being existential, but the 2025 balance sheet is clearly thinner than it was.
Growth & Trajectory5/10
The structural tailwinds are genuine — AI data centers, semiconductor reshoring, and energy transition capex represent a real multi-year spending wave — but current revenue is slightly declining and the earnings trajectory is manufactured noise rather than organic momentum. The 87% reimbursable mix on new awards is the single most important leading indicator; if that holds, trajectory improves meaningfully from here.
Valuation3/10at $45.82
Trading materially above the stated DCF fair value while producing deeply negative earnings yield and free cash flow yield, with no reliable multiple framework available given the earnings volatility — the P/S looks superficially attractive for a contractor but is cold comfort when operating margins can go negative in a single quarter. The SMR licensing wildcard is the only scenario where current price makes intuitive sense, and it remains pre-commercial.
Risk3/10
The Santos arbitration was not a black swan — it was a predictable consequence of the contract type Fluor was supposedly moving away from, and the mid-2026 appeal creates another binary event horizon that could trigger a second large cash outflow. Governance ambiguity at the top, recurrent project write-downs, and the pattern of ROIC swinging violently negative every few years add up to a risk profile that is elevated relative to how the stock is currently priced.
Fluor is a legitimately interesting turnaround embedded inside a structurally thin-margin business. The pivot to reimbursable contracts and the secular tailwinds from semiconductor fabs and data center buildouts are not hype — they represent real, multi-year capital spending by clients who need exactly what Fluor provides. The problem is that investors are being asked to pay for a transformation whose proof is still accumulating, from a management team whose prior high-conviction bets burned shareholders twice. When quality is uncertain and the price already reflects optimism, the margin of safety evaporates. The business is heading in the right direction: an 87% reimbursable new awards mix, a backlog anchored in government and advanced manufacturing rather than lump-sum LNG, and Mission Solutions providing a sticky, clearance-gated revenue base that larger technology primes cannot easily displace. If the contract mix genuinely holds and project execution stabilizes, the earnings volatility that has perpetually depressed the multiple could compress structurally — and the market would be looking at a very different business than the one that nearly collapsed under fixed-price overruns. The single biggest specific risk is not Santos itself — it's the pattern Santos represents. Each time Fluor reaches for a larger, more complex project with aggressive contract terms, a write-down follows that erases multiple years of accumulated earnings in a single charge. The appeal hearing in mid-2026 is a discrete binary event, but the deeper risk is that the organizational discipline required to permanently avoid this failure mode hasn't been tested across a full project cycle under the new strategy. One more catastrophic fixed-price contract, and the turnaround narrative resets to zero.